Literature DB >> 29923177

BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia.

Adam J de Smith1,2, Kyle M Walsh1,3, Stephen S Francis4, Chenan Zhang1,5, Helen M Hansen5, Ivan Smirnov5, Libby Morimoto6, Todd P Whitehead6, Alice Kang6, Xiaorong Shao6, Lisa F Barcellos6, Roberta McKean-Cowdin2, Luoping Zhang6, Cecilia Fu7, Rong Wang8, Herbert Yu9, Josephine Hoh8, Andrew T Dewan8, Catherine Metayer6, Xiaomei Ma8, Joseph L Wiemels1,2,5.   

Abstract

Genome-wide association studies of childhood acute lymphoblastic leukemia (ALL) have identified regions of association at PIP4K2A and upstream of BMI1 at chromosome 10p12.31-12.2. The contribution of both loci to ALL risk and underlying functional variants remain to be elucidated. We carried out single nucleotide polymorphism (SNP) imputation across chromosome 10p12.31-12.2 in Latino and non-Latino white ALL cases and controls from two independent California childhood leukemia studies, and additional Genetic Epidemiology Research on Aging study controls. Ethnicity-stratified association analyses were performed using logistic regression, with meta-analysis including 3,133 cases (1,949 Latino, 1,184 non-Latino white) and 12,135 controls (8,584 Latino, 3,551 non-Latino white). SNP associations were identified at both BMI1 and PIP4K2A. After adjusting for the lead PIP4K2A SNP, genome-wide significant associations remained at BMI1, and vice-versa (pmeta < 10-10 ), supporting independent effects. Lead SNPs differed by ethnicity at both peaks. We sought functional variants in tight linkage disequilibrium with both the lead Latino SNP among Admixed Americans and lead non-Latino white SNP among Europeans. This pinpointed rs11591377 (pmeta = 2.1 x 10-10 ) upstream of BMI1, residing within a hematopoietic stem cell enhancer of BMI1, and which showed significant preferential binding of the risk allele to MYBL2 (p = 1.73 x 10-5 ) and p300 (p = 1.55 x 10-3 ) transcription factors using binomial tests on ChIP-Seq data from a SNP heterozygote. At PIP4K2A, we identified rs4748812 (pmeta = 1.3 x 10-15 ), which alters a RUNX1 binding motif and demonstrated chromosomal looping to the PIP4K2A promoter. Fine-mapping chromosome 10p12 in a multi-ethnic ALL GWAS confirmed independent associations and identified putative functional variants upstream of BMI1 and at PIP4K2A.
© 2018 UICC.

Entities:  

Keywords:  BMI1; childhood acute lymphoblastic leukemia; enhancer element; fine-mapping; genome-wide association study

Mesh:

Substances:

Year:  2018        PMID: 29923177      PMCID: PMC6235695          DOI: 10.1002/ijc.31622

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.316


  58 in total

1.  Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Authors:  Amy L Sherborne; Fay J Hosking; Rashmi B Prasad; Rajiv Kumar; Rolf Koehler; Jayaram Vijayakrishnan; Elli Papaemmanuil; Claus R Bartram; Martin Stanulla; Martin Schrappe; Andreas Gast; Sara E Dobbins; Yussanne Ma; Eamonn Sheridan; Malcolm Taylor; Sally E Kinsey; Tracey Lightfoot; Eve Roman; Julie A E Irving; James M Allan; Anthony V Moorman; Christine J Harrison; Ian P Tomlinson; Sue Richards; Martin Zimmermann; Csaba Szalai; Agnes F Semsei; Daniel J Erdelyi; Maja Krajinovic; Daniel Sinnett; Jasmine Healy; Anna Gonzalez Neira; Norihiko Kawamata; Seishi Ogawa; H Phillip Koeffler; Kari Hemminki; Mel Greaves; Richard S Houlston
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.

Authors:  Gabriele Migliorini; Bettina Fiege; Fay J Hosking; Yussanne Ma; Rajiv Kumar; Amy L Sherborne; Miguel Inacio da Silva Filho; Jayaram Vijayakrishnan; Rolf Koehler; Hauke Thomsen; Julie A Irving; James M Allan; Tracy Lightfoot; Eve Roman; Sally E Kinsey; Eamonn Sheridan; Pamela Thompson; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Martin Zimmermann; Claus R Bartram; Martin Schrappe; Mel Greaves; Martin Stanulla; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2013-08-30       Impact factor: 22.113

3.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.

Authors:  M Arsura; M Introna; F Passerini; A Mantovani; J Golay
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

4.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

5.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

6.  EnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell/tissue types.

Authors:  Tianshun Gao; Bing He; Sheng Liu; Heng Zhu; Kai Tan; Jiang Qian
Journal:  Bioinformatics       Date:  2016-08-10       Impact factor: 6.937

7.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

8.  Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements.

Authors:  Maxwell R Mumbach; Ansuman T Satpathy; Evan A Boyle; Chao Dai; Benjamin G Gowen; Seung Woo Cho; Michelle L Nguyen; Adam J Rubin; Jeffrey M Granja; Katelynn R Kazane; Yuning Wei; Trieu Nguyen; Peyton G Greenside; M Ryan Corces; Josh Tycko; Dimitre R Simeonov; Nabeela Suliman; Rui Li; Jin Xu; Ryan A Flynn; Anshul Kundaje; Paul A Khavari; Alexander Marson; Jacob E Corn; Thomas Quertermous; William J Greenleaf; Howard Y Chang
Journal:  Nat Genet       Date:  2017-09-25       Impact factor: 38.330

9.  Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1.

Authors:  Aleksandra Rizo; Bert Dontje; Edo Vellenga; Gerald de Haan; Jan Jacob Schuringa
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

10.  Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.

Authors:  Melinda C Aldrich; Luoping Zhang; Joseph L Wiemels; Xiaomei Ma; Mignon L Loh; Catherine Metayer; Steve Selvin; James Feusner; Martyn T Smith; Patricia A Buffler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-03       Impact factor: 4.254

View more
  12 in total

1.  NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2.

Authors:  Femke M Hormann; Alex Q Hoogkamer; H Berna Beverloo; Aurélie Boeree; Ilse Dingjan; Moniek M Wattel; Ronald W Stam; Gabriele Escherich; Rob Pieters; Monique L den Boer; Judith M Boer
Journal:  Haematologica       Date:  2019-03-14       Impact factor: 9.941

2.  Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.

Authors:  Adam J de Smith; Geneviève Lavoie; Kyle M Walsh; Sumeet Aujla; Erica Evans; Helen M Hansen; Ivan Smirnov; Alice Y Kang; Martin Zenker; John J Ceremsak; Elliot Stieglitz; Ivo S Muskens; William Roberts; Roberta McKean-Cowdin; Catherine Metayer; Philippe P Roux; Joseph L Wiemels
Journal:  Genes Chromosomes Cancer       Date:  2019-05-27       Impact factor: 5.006

3.  Genetic determinants of blood-cell traits influence susceptibility to childhood acute lymphoblastic leukemia.

Authors:  Linda Kachuri; Soyoung Jeon; Andrew T DeWan; Catherine Metayer; Xiaomei Ma; John S Witte; Charleston W K Chiang; Joseph L Wiemels; Adam J de Smith
Journal:  Am J Hum Genet       Date:  2021-08-31       Impact factor: 11.043

Review 4.  Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children.

Authors:  Oskar A Haas; Arndt Borkhardt
Journal:  Leukemia       Date:  2022-10-20       Impact factor: 12.883

5.  Leveraging Genome and Phenome-Wide Association Studies to Investigate Genetic Risk of Acute Lymphoblastic Leukemia.

Authors:  Eleanor C Semmes; Jayaram Vijayakrishnan; Chenan Zhang; Jillian H Hurst; Richard S Houlston; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

6.  Cancer Progress and Priorities: Childhood Cancer.

Authors:  Philip J Lupo; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06       Impact factor: 4.090

7.  Enhancer polymorphisms at the IKZF1 susceptibility locus for acute lymphoblastic leukemia impact B-cell proliferation and differentiation in both Down syndrome and non-Down syndrome genetic backgrounds.

Authors:  Vincent U Gant; Jacob J Junco; Maci Terrell; Raushan Rashid; Karen R Rabin
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

Review 8.  Genetic Variants in Transcription Factor Binding Sites in Humans: Triggered by Natural Selection and Triggers of Diseases.

Authors:  Chia-Chun Tseng; Man-Chun Wong; Wei-Ting Liao; Chung-Jen Chen; Su-Chen Lee; Jeng-Hsien Yen; Shun-Jen Chang
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

9.  Novel Associations Between METTL3 Gene Polymorphisms and Pediatric Acute Lymphoblastic Leukemia: A Five-Center Case-Control Study.

Authors:  Xiaoping Liu; Libin Huang; Ke Huang; Lihua Yang; Xu Yang; Ailing Luo; Mansi Cai; Xuedong Wu; Xiaodan Liu; Yaping Yan; Jianyun Wen; Yun Cai; Ling Xu; Hua Jiang
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

10.  Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.

Authors:  Austin L Brown; Adam J de Smith; Vincent U Gant; Wenjian Yang; Michael E Scheurer; Kyle M Walsh; Jonathan M Chernus; Noah A Kallsen; Shanna A Peyton; Gareth E Davies; Erik A Ehli; Naomi Winick; Nyla A Heerema; Andrew J Carroll; Michael J Borowitz; Brent L Wood; William L Carroll; Elizabeth A Raetz; Eleanor Feingold; Meenakshi Devidas; Lisa F Barcellos; Helen M Hansen; Libby Morimoto; Alice Y Kang; Ivan Smirnov; Jasmine Healy; Caroline Laverdière; Daniel Sinnett; Jeffrey W Taub; Jillian M Birch; Pamela Thompson; Logan G Spector; Maria S Pombo-de-Oliveira; Andrew T DeWan; Charles G Mullighan; Stephen P Hunger; Ching-Hon Pui; Mignon L Loh; Michael E Zwick; Catherine Metayer; Xiaomei Ma; Beth A Mueller; Stephanie L Sherman; Joseph L Wiemels; Mary V Relling; Jun J Yang; Philip J Lupo; Karen R Rabin
Journal:  Blood       Date:  2019-10-10       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.